Study to Gather Information About the Proper Dosing and Safety of the Oral FXIa Inhibitor BAY 2433334 in Patients Following an Acute Heart Attack
Clinical trial NCT04304534 · COMPLETED
Trial details
- NCT number
- NCT04304534
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-17
- Primary completion
- 2022-02-21
- Enrollment
- 1601
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.